Jordan Graves
COO, Elastin Biosciences
Elastin Biosciences develops a platform to reverse extracellular-matrix aging. Its therapeutics block degradation and promote elastin synthesis, targeting structural decline in skin, lungs, and vessels to extend healthspan.
Events Jordan Graves has spoken at
- BioTrinity 2026 14 April 2026 – 15 April 2026